$MNKD
MANNKIND CORP

2015 Q4 Form 10-K Financial Statement

#000119312516505366 Filed on March 15, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $51.80M $64.75M
YoY Change
Gross Profit -$51.80M -$64.75M
YoY Change
Gross Profit Margin
Selling, General & Admin $8.300M $40.96M $12.50M
YoY Change -33.6% -48.4% -28.98%
% of Gross Profit
Research & Development $6.200M $29.67M $17.60M
YoY Change -64.77% -70.4% -39.31%
% of Gross Profit
Depreciation & Amortization $3.190M $11.00M $3.010M
YoY Change 5.98% 12.24% -23.8%
% of Gross Profit
Operating Expenses $14.50M $344.7M $30.10M
YoY Change -51.83% 91.87% -35.41%
Operating Profit -$66.30M -$344.7M
YoY Change 91.87%
Interest Expense -$4.100M $24.10M -$6.400M
YoY Change -35.94% 18.14% 1.59%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$23.79M $0.00
YoY Change 26.85% -100.0%
Pretax Income -$277.0M -$368.4M -$36.40M
YoY Change 660.99% 85.73% -32.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$277.0M -$368.4M -$36.44M
YoY Change 660.23% 85.73% -31.99%
Net Earnings / Revenue
Basic Earnings Per Share -$4.54
Diluted Earnings Per Share -$3.302M -$4.54 -$458.4K
COMMON SHARES
Basic Shares Outstanding 409.5M shares 81.23M 405.7M shares
Diluted Shares Outstanding 81.23M

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.10M $59.10M $120.8M
YoY Change -51.08% -51.08% 70.62%
Cash & Equivalents $59.07M $59.10M $120.8M
Short-Term Investments
Other Short-Term Assets $17.50M $17.50M $20.20M
YoY Change -13.37% -13.37% 267.27%
Inventory $0.00 $0.00 $9.670M
Prepaid Expenses $15.00M $15.00M
Receivables $23.00K $0.00 $50.44M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $76.65M $76.70M $201.2M
YoY Change -61.89% -61.88% 163.72%
LONG-TERM ASSETS
Property, Plant & Equipment $48.75M $48.70M $192.1M
YoY Change -74.63% -74.65% 8.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.009M $1.000M $848.0K
YoY Change 18.99% -16.67% -84.63%
Total Long-Term Assets $49.76M $49.70M $193.3M
YoY Change -74.26% -74.28% 5.99%
TOTAL ASSETS
Total Short-Term Assets $76.65M $76.70M $201.2M
Total Long-Term Assets $49.76M $49.70M $193.3M
Total Assets $126.4M $126.4M $394.4M
YoY Change -67.95% -67.95% 52.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.60M $15.60M $7.394M
YoY Change 110.97% 110.81% 91.55%
Accrued Expenses $7.929M $6.300M $26.21M
YoY Change -69.74% -63.58% 21.13%
Deferred Revenue
YoY Change
Short-Term Debt $74.60M $74.60M $73.00M
YoY Change 2.19% 2.19% -28.64%
Long-Term Debt Due $0.00 $0.00 $99.40M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $268.3M $268.3M $403.4M
YoY Change -33.48% -33.49% 215.63%
LONG-TERM LIABILITIES
Long-Term Debt $139.5M $139.5M $52.60M
YoY Change 165.21% 165.21% -64.46%
Other Long-Term Liabilities $15.23M $68.90M $12.30M
YoY Change 23.77% 460.16% -9.58%
Total Long-Term Liabilities $15.23M $208.4M $12.30M
YoY Change 23.77% 221.11% -9.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $268.3M $268.3M $403.4M
Total Long-Term Liabilities $15.23M $208.4M $12.30M
Total Liabilities $476.7M $476.7M $468.2M
YoY Change 1.82% 1.82% 61.81%
SHAREHOLDERS EQUITY
Retained Earnings -$2.863B -$2.495B
YoY Change 14.77% 8.64%
Common Stock $2.513B $2.421B
YoY Change 3.8% 6.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$350.3M -$350.3M -$73.77M
YoY Change
Total Liabilities & Shareholders Equity $126.4M $126.4M $394.4M
YoY Change -67.95% -67.95% 52.5%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$277.0M -$368.4M -$36.44M
YoY Change 660.23% 85.73% -31.99%
Depreciation, Depletion And Amortization $3.190M $11.00M $3.010M
YoY Change 5.98% 12.24% -23.8%
Cash From Operating Activities -$22.55M -$57.23M -$35.74M
YoY Change -36.91% -1499.27% 4.96%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K $10.29M -$4.970M
YoY Change -93.56% -57.32% -19.45%
Acquisitions
YoY Change
Other Investing Activities $0.00 $80.00K -$9.250M
YoY Change -100.0%
Cash From Investing Activities -$310.0K -$10.20M -$14.22M
YoY Change -97.82% -57.68% 130.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $28.39M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.01M 5.670M -1.670M
YoY Change -3034.73% -91.91% -109.71%
NET CHANGE
Cash From Operating Activities -22.55M -57.23M -35.74M
Cash From Investing Activities -310.0K -10.20M -14.22M
Cash From Financing Activities 49.01M 5.670M -1.670M
Net Change In Cash 26.15M -61.76M -51.63M
YoY Change -150.65% -223.4% 124.28%
FREE CASH FLOW
Cash From Operating Activities -$22.55M -$57.23M -$35.74M
Capital Expenditures -$320.0K $10.29M -$4.970M
Free Cash Flow -$22.23M -$67.52M -$30.77M
YoY Change -27.75% 237.46% 10.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 mnkd Units Sold Warrant Portion Convertible Into Common Stock
UnitsSoldWarrantPortionConvertibleIntoCommonStock
0.6
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten
UnitsSoldUnderPublicOfferUnderwritten
35937500 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
159303 shares
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
428850858 shares
CY2004Q3 mnkd Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
216000000
CY2015Q2 dei Entity Public Float
EntityPublicFloat
1461620053
CY2015Q3 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2015Q4 mnkd Shares Returned Under Share Lending Agreement
SharesReturnedUnderShareLendingAgreement
9000000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-110679000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2013Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30713000
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70790000
CY2013Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
282000
CY2013Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21541664 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2014Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
406059089 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2610720 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.53
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.20
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
406059089 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403353000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14928000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118221000
CY2014Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2014Q4 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
3034000
CY2014Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
1343000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26206000
CY2014Q4 us-gaap Liabilities
Liabilities
468209000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
4061000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2416967000
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2396000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12301000
CY2014Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
72995000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
196967000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
99355000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
882502000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7539000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2494784000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-73770000
CY2014Q4 mnkd Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
9670000
CY2014Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
30100000
CY2014Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
3500000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
19597097 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19779229 shares
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
699997000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20206000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50436000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
310348000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
848000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
73227000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
15540652 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.47
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
394439000
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
300000
CY2014Q4 us-gaap Other Deferred Credits Current
OtherDeferredCreditsCurrent
436000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7394000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
95000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
192127000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
201153000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
43691000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33495000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
768000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4856000
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
19217000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3010000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120841000
CY2014Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
311000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4719000
CY2014Q4 us-gaap Assets
Assets
394439000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
882502000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
131000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Inventory Net
InventoryNet
9670000
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
118500000
CY2014Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
816000
CY2014Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2014Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
5321000
CY2014Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2014Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
28516000
CY2014Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
8624000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
428670943 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
23300000
CY2015Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
27613000
CY2015Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
23300000
CY2015Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
28800000
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
3000000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
35000000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
4287000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2508633000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126412000
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.61
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
17217332 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.53
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1804620 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.54
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.85
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
428670943 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
268319000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5662000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
119513000
CY2015Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2015Q4 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
62371000
CY2015Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
238000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7929000
CY2015Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
30100000
CY2015Q4 us-gaap Liabilities
Liabilities
476741000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20000000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5000000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
615000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15225000
CY2015Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
74582000
CY2015Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
23300000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
140231000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
962623000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1414000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2863229000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-350329000
CY2015Q4 us-gaap Purchase Obligation
PurchaseObligation
116200000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15599000
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2015Q4 us-gaap Other Deferred Credits Current
OtherDeferredCreditsCurrent
17503000
CY2015Q4 us-gaap Purchase Obligation
PurchaseObligation
98500000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
76654000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48749000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
16941000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
251000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
52484000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
48755000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15000000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1900000000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59074000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1300000000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2015Q4 us-gaap Assets
Assets
126412000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
962623000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
7186000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
721588000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4018000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
308674000
CY2015Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
13539000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1009000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
73646000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
55800000
CY2015Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
743000
CY2015Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
3242000
CY2015Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
5872000
CY2015Q4 mnkd Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest
ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest
1651859 shares
CY2015Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
8574000
CY2015Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
30100000
CY2015Q4 mnkd Weighted Average Grant Date Fair Value Of Restricted Stock Units Expected To Vest
WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest
4.86
CY2015Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
6400000
CY2015Q4 mnkd Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
24084000
CY2015Q4 mnkd Purchase Obligation Current
PurchaseObligationCurrent
12475000
CY2015Q4 mnkd Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
53692000
CY2012Q1 mnkd Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
80600000
CY2015Q4 mnkd Class Of Warrant Exercise Price Of Warrants Stated As Percentage Of Offering Price
ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice
0.0115 pure
CY2014Q3 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
120100000
CY2015Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
198 Employee
CY2015Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.26 pure
CY2015Q4 us-gaap Payments For Restructuring
PaymentsForRestructuring
2800000
CY2004Q1 mnkd Percentage Of Common Stock Shares Outstanding
PercentageOfCommonStockSharesOutstanding
0.01 pure
CY2004Q3 mnkd Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
13000000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7583 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
78475367 shares
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
463290 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8626 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.307 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-128732000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0094 pure
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.26
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
299591000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0182 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.043 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M2D
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-191488000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7987000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48888000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45186000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-635000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1263000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-169401000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-191490000
CY2013 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
7886000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
998000
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4801000
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1103000
CY2013 us-gaap Interest Paid
InterestPaid
13452000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
66800000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2270000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
499000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-191490000
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
2000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2013 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
856000
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
6500000
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4801000
CY2013 us-gaap Interest Expense
InterestExpense
21500000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
49990000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
14900000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
645000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2013 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-66849000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14057000
CY2013 us-gaap Operating Expenses
OperatingExpenses
169401000
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
145669000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11500000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59682000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
59379000
CY2013 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
119500000
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
109719000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
2300000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
13900000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3100000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8950000
CY2013 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6309000
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
15153000
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
94147000
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
533000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45186000
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
591000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2013 us-gaap Restructuring Charges
RestructuringCharges
400000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1071000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7470000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
45186000
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7987000
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3675000
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2013 mnkd Stock Issued During Period Value For Debt Exchange
StockIssuedDuringPeriodValueForDebtExchange
5501000
CY2013 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-817000
CY2013 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
78000000
CY2013 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2013 mnkd Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
172149000
CY2013 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
3534000
CY2013 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
82000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7398 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51463340 shares
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
305076 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8485 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.318 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4086000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0164 pure
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.76
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
385229000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0211 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.041 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M22D
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
615000
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-198392000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24097000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25660000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1679000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1363000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-179627000
CY2014 us-gaap Loans Assumed1
LoansAssumed1
3034000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9670000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-198382000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
22962000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26908000
CY2014 us-gaap Interest Paid
InterestPaid
11218000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
65500000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10978000
CY2014 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
50436000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14734000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-198382000
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-10000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2014 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1768000
CY2014 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
93500000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-26908000
CY2014 us-gaap Interest Expense
InterestExpense
20400000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
36400000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
737000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2014 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-65504000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18575000
CY2014 us-gaap Operating Expenses
OperatingExpenses
179627000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
70062000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9800000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
79383000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
57873000
CY2014 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
40000000
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
800000
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
100244000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
11000000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
62700000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14900000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
50051000
CY2014 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2894000
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
17549000
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
27779000
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
623000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48622000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2915000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2014 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
200436000
CY2014 us-gaap Restructuring Charges
RestructuringCharges
1900000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3622000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7631000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
48622000
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24097000
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2276000
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2014 mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
CY2014 mnkd Stock Issued During Period Value For Debt Exchange
StockIssuedDuringPeriodValueForDebtExchange
93501000
CY2014 mnkd Nominal Lending Fee
NominalLendingFee
0.01
CY2014 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-97000
CY2014 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
0.009 pure
CY2014 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2014 mnkd Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
27779000
CY2014 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
12341000
CY2014 mnkd Milestone Payments
MilestonePayments
3150000
CY2014 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
79000
CY2015 dei Document Type
DocumentType
10-K
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
896184 shares
CY2015 dei Trading Symbol
TradingSymbol
MNKD
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000899460
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.88
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6976 pure
CY2015 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
828370 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29731254 shares
CY2015 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
321228 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
706387 shares
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7184 pure
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> &#x2014;&#xA0;Financial instruments which potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents consist of interest-bearing accounts, which are regularly monitored by management and held in high credit quality institutions.</font></p> </div>
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.338 pure
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.11
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.14
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-57232000
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0161 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1111134 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1133404 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.78
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.91
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1700964 shares
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.56
CY2015 dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
5500000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
426000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-80118000
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial Statement Estimates</i> &#x2014;&#xA0;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. The more significant estimates reflected in these accompanying financial statements involve assessing long-lived assets for impairment, accrued expenses, including clinical study expenses, inventory recoverability, valuation of the facility financing obligation, commitment asset, milestone rights, valuation of stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities and any valuation allowance recorded against net deferred tax assets.</font></p> </div>
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
406165000 shares
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.70
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.93
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0186 pure
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.012 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M19D
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13276000
CY2015 us-gaap Operating Expenses
OperatingExpenses
344655000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1541100 shares
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
80100000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3258000
CY2015 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-50413000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-150000
CY2015 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
13539000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1049000
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2697000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-368451000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10285000
CY2015 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
40000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2015 us-gaap Stock Issued1
StockIssued1
8253000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27844000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8725000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1366000
CY2015 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-1049000
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
887000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-344655000
CY2015 us-gaap Loans Assumed1
LoansAssumed1
59337000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26434000
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
-202000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-368445000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-1856000
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2015 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-66167000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1858000
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
548000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7926000
CY2015 us-gaap Interest Paid
InterestPaid
13355000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13485000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-368445000
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2015 us-gaap Interest Expense
InterestExpense
24100000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28392000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
1652000
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
36300000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5668000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11000000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40960000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
109512000
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
29674000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
242700000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17067000
CY2015 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
3300000
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
82000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
5200000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6200000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-61767000
CY2015 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2894000
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
21231000
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10123000
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
593000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8725000
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2927000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Manufacturing Costs
ManufacturingCosts
67442000
CY2015 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
950000
CY2015 us-gaap Restructuring Charges
RestructuringCharges
5900000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8413000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-29394000
CY2015 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
36104000
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
40000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
8725000
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
140412000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10203000
CY2015 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-12467000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2015 mnkd Stock Issued During Period Value Share Lending Agreement
StockIssuedDuringPeriodValueShareLendingAgreement
160000
CY2015 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-140582000
CY2015 mnkd Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity
108000
CY2015 mnkd Value Of Restricted Stock Units Vested
ValueOfRestrictedStockUnitsVested
2400000
CY2015 mnkd Adjustments To Additional Paid In Capital Stock Option Issued Upon Debt Conversion
AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion
169000
CY2015 mnkd Deferred Tax Asset Increase Decrease In Equity
DeferredTaxAssetIncreaseDecreaseInEquity
10000000
CY2015 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2015 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2019-12-31
CY2015 mnkd Stock Options Granted Vesting Rate
StockOptionsGrantedVestingRate
0.25 pure
CY2015 mnkd Class Of Warrants Or Rights Expiration Date
ClassOfWarrantsOrRightsExpirationDate
2016-02-08
CY2015 mnkd Maturity Period Of Cash Equivalents
MaturityPeriodOfCashEquivalents
90 days or less at the time of purchase
CY2015 mnkd Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
0
CY2015 mnkd Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
10123000
CY2015 mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
CY2015 mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
CY2015 mnkd Long Term Purchase Commitment Cancellation Fees
LongTermPurchaseCommitmentCancellationFees
5200000
CY2015 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
4146000
CY2015 mnkd Milestone Payments
MilestonePayments
4219000
CY2015 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
18000
CY2015 mnkd Number Of Asset Groups
NumberOfAssetGroups
2 asset_group
CY2015 mnkd Class Of Warrant Exercisable Period
ClassOfWarrantExercisablePeriod
P5Y
CY2015 mnkd Gain Loss On Purchase Commitments
GainLossOnPurchaseCommitments
-66167000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-52056000
CY2014Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
368784000 shares
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-30658000
CY2015Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
398916000 shares
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-73365000
CY2014Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
380770000 shares
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-28910000
CY2015Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
401018000 shares
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-36520000
CY2014Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
394163000 shares
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-31857000
CY2015Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
405199000 shares
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-36439000
CY2014Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
396793000 shares
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-277020000
CY2015Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
419314000 shares

Files In Submission

Name View Source Status
0001193125-16-505366-index-headers.html Edgar Link pending
0001193125-16-505366-index.html Edgar Link pending
0001193125-16-505366.txt Edgar Link pending
0001193125-16-505366-xbrl.zip Edgar Link pending
d107849d10k.htm Edgar Link pending
d107849dex1036.htm Edgar Link pending
d107849dex1037.htm Edgar Link pending
d107849dex1038.htm Edgar Link pending
d107849dex108.htm Edgar Link pending
d107849dex231.htm Edgar Link pending
d107849dex31.htm Edgar Link pending
d107849dex32.htm Edgar Link pending
d107849dex417.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g1078491.jpg Edgar Link pending
g1078492.jpg Edgar Link pending
g1078493.jpg Edgar Link pending
g1078494.jpg Edgar Link pending
g1078495.jpg Edgar Link pending
g1078496.jpg Edgar Link pending
g1078497.jpg Edgar Link pending
g1078498.jpg Edgar Link pending
g1078499.jpg Edgar Link pending
g107849ex10_37.jpg Edgar Link pending
g107849ex10_39.jpg Edgar Link pending
g107849ex10_40.jpg Edgar Link pending
g107849g85o46.jpg Edgar Link pending
mnkd-20151231.xml Edgar Link completed
mnkd-20151231.xsd Edgar Link pending
mnkd-20151231_cal.xml Edgar Link unprocessable
mnkd-20151231_def.xml Edgar Link unprocessable
mnkd-20151231_lab.xml Edgar Link unprocessable
mnkd-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending